Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Balchem (BCPC) Cost of Revenue (2016 - 2025)

Balchem (BCPC) has disclosed Cost of Revenue for 16 consecutive years, with $20.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 17.16% to $20.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $75.4 million, a 63.91% decrease, with the full-year FY2025 number at $75.4 million, up 9.37% from a year prior.
  • Cost of Revenue was $20.1 million for Q4 2025 at Balchem, up from $19.1 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $158.1 million in Q1 2024 to a low of -$346.4 million in Q4 2021.
  • A 5-year average of $4.8 million and a median of $17.5 million in 2022 define the central range for Cost of Revenue.
  • Biggest YoY gain for Cost of Revenue was 862.44% in 2023; the steepest drop was 1656.05% in 2023.
  • Balchem's Cost of Revenue stood at -$346.4 million in 2021, then skyrocketed by 105.15% to $17.8 million in 2022, then increased by 8.01% to $19.3 million in 2023, then dropped by 11.18% to $17.1 million in 2024, then rose by 17.16% to $20.1 million in 2025.
  • Per Business Quant, the three most recent readings for BCPC's Cost of Revenue are $20.1 million (Q4 2025), $19.1 million (Q3 2025), and $19.3 million (Q2 2025).